Search

Your search keyword '"Maho-Vaillant, Maud"' showing total 34 results

Search Constraints

Start Over You searched for: Author "Maho-Vaillant, Maud" Remove constraint Author: "Maho-Vaillant, Maud"
34 results on '"Maho-Vaillant, Maud"'

Search Results

1. The emergence of circulating activated autoreactive desmoglein 3-specific follicular regulatory T cells is associated with long-term efficacy of rituximab in patients with pemphigus vulgaris.

5. First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial

6. Sustained Remission Without Corticosteroids Among Patients With Pemphigus Who Had Rituximab as First-Line Therapy: Follow-Up of the Ritux 3 Trial.

9. IgG N-glycosylation from Patients with Pemphigus Treated with Rituximab

10. FcRn Antagonism Leads to a Decrease of Desmoglein-Specific B Cells

11. FcRn Antagonism Leads to a Decrease of Desmoglein-Specific B Cells: Secondary Analysis of a Phase 2 Study of Efgartigimod in Pemphigus Vulgaris and Pemphigus Foliaceus

12. FcRn Antagonism Leads to a Decrease of Desmoglein-Specific B Cells: Secondary Analysis of a Phase 2 Study of Efgartigimod in Pemphigus Vulgaris and Pemphigus Foliaceus

13. The Diversity of Serum Anti-DSG3 IgG Subclasses Has a Major Impact on Pemphigus Activity and Is Predictive of Relapses After Treatment With Rituximab

17. Longitudinal Pathogenic Properties and N-Glycosylation Profile of Antibodies from Patients with Pemphigus after Corticosteroid Treatment

19. Factors Associated With Short-term Relapse in Patients With Pemphigus Who Receive Rituximab as First-line Therapy

21. Modifications of the Transcriptomic Profile of Autoreactive BCells From Pemphigus Patients After Treatment With Rituximab or a StandardCorticosteroid Regimen

23. Longitudinal study of anti-DSG3 IgG repertoire by proteomics in Pemphigus following Rituximab treatment

27. Human Regulatory B Cells Combine Phenotypic and Genetic Hallmarks with a Distinct Differentiation Fate

29. Long-Term Remissions of Severe Pemphigus After Rituximab Therapy Are Associated with Prolonged Failure of Desmoglein B Cell Response

31. Human Regulatory B Cells Combine Phenotypic and Genetic Hallmarks with a Distinct Differentiation Fate.

32. Methods to Study the Transcriptome of Regulatory B Cells.

33. Factors Associated With Short-term Relapse in Patients With Pemphigus Who Receive Rituximab as First-line Therapy: A Post Hoc Analysis of a Randomized Clinical Trial.

34. CD11c + B Cells Are Mainly Memory Cells, Precursors of Antibody Secreting Cells in Healthy Donors.

Catalog

Books, media, physical & digital resources